{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:13:18Z","timestamp":1788786798642,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"publisher","award":["Grant 19-318"],"award-info":[{"award-number":["Grant 19-318"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study was conducted to estimate the direct non-medical cost of advanced non-small cell lung cancer (NSCLC) patients and explore whether its associated factors vary by health status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were obtained from 13 centers in five provinces for patients with advanced NSCLC in China. The direct non-medical cost of patients since the patients were diagnosed with NSCLC included the cost of transportation, accommodation, meal, hired caregiving, and nutrition. We measured patients' health status by EQ-5D-5L instrument and divided them into good (\u22650.75) and poor (&amp;lt;0.75) groups based on the utility score. A generalized linear model (GLM) was used to assess independent associations between statistically significant factors and non-medical financial burden in health status subgroups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data from 607 patients were analyzed. The direct non-medical cost associated with advanced NSCLC since diagnosis was $2,951 per case ($4,060 in the poor health group and $2,505 in the other), with nutrition costing the most. GLM results showed that residence(Urban area vs. Rural area: \u22121.038, [\u22122.056, \u22120.02]), caregivers' occupation type (Farmer vs. Employee: \u22121.303, [\u22122.514, \u22120.093]), hospitalization frequency (0.077, [0.033, 0.12]), average length of hospital stay (0.101, [0.032, 0.17]), and pathological type (Squamous carcinoma vs. Non-squamous carcinoma: \u22120.852, [\u22121.607, \u22120.097]) were independent factors influencing direct non-medical cost in the poor health group. Among participants with good health status, residence (Urban area vs. Rural area: \u22120.621, [\u22121.005, \u22120.236]), marital status (Others vs. Married: 0.762, [0.035, 1.488]), patients' employment status, current caregiving time per day (more than 9 hours per day vs. less than 3 hours per day: 0.471, [0.134, 0.807]), duration of disease (0.015, [0.007, 0.024]), and hospitalization frequency (0.091, [0.068, 0.113]) were statistically associated factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The direct non-medical economic burden of advanced NSCLC patients in China is considerable and differs by health status. Strengthening accessibility for more effective therapies and early nutritional intervention to improve prognosis, and further promoting accessible care forms within relevant healthcare insurance coverage may be potentially feasible approaches to alleviate the direct non-medical economic burden for patients and their families.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1090623","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:17:09Z","timestamp":1683173829000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?"],"prefix":"10.3389","volume":"11","author":[{"given":"Yu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enwu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","article-title":"Cancer incidence and mortality in China, 2016","volume":"2","author":"Zheng","year":"2022","journal-title":"J Natl Cancer Center."},{"key":"B2","unstructured":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.ejso.2020.08.013","article-title":"The progression of non-small cell lung cancer from diagnosis to surgery","volume":"46","author":"McPherson","year":"2020","journal-title":"Eur J Surg Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1016\/S2468-2667(21)00157-2","article-title":"Disparities in stage at diagnosis for five common cancers in China: A multicentre, hospital-based, observational study","volume":"6","author":"Zeng","year":"2021","journal-title":"Lancet Public Health."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1007\/s00432-022-04258-w","article-title":"Measuring the indirect cost associated with advanced non-small cell lung cancer: A nationwide cross-sectional study in China","volume":"22","author":"Yang","year":"2022","journal-title":"J Cancer Res Clin Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00432-016-2326-x","article-title":"Economic burden of patients affected by non-small cell lung cancer (NSCLC): The LIFE study","volume":"143","author":"Migliorino","year":"2017","journal-title":"J Cancer Res Clin Oncol."},{"key":"B7","first-page":"240","article-title":"Analysis of influencing factors and cost control of inpatients with non-small cell lung cancer","volume":"29","author":"Ding","year":"2012","journal-title":"Chin J Health Stat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.19485\/j.cnki.issn1007-0931.2017.07.009","article-title":"An analysis on non-medical cost contributed by smoking of smoking related diseasesin main urban districts of Hanazhou","volume":"29","author":"Yang","year":"2017","journal-title":"Prev Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"30308","DOI":"10.3390\/ijerph14030308","article-title":"Economic burden for lung cancer survivors in urban China","volume":"14","author":"Zhang","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/tobaccocontrol-2018-054767","article-title":"Economic burden of lung cancer attributable to smoking in China in 2015","volume":"29","author":"Shi","year":"2020","journal-title":"Tob Control."},{"key":"B11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/thx.2010.136390","article-title":"Health-related quality of life in patients surviving non-small cell lung cancer","volume":"65","author":"Grutters","year":"2010","journal-title":"Thorax."},{"key":"B12","doi-asserted-by":"publisher","first-page":"b013e318299243b","DOI":"10.1097\/JTO.0b013e318299243b","article-title":"Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: A prospective cross-sectional patient survey in a real-world setting","volume":"8","author":"Chouaid","year":"2013","journal-title":"J Thorac Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.3969\/j.issn.1005-9202.2016.23.083","article-title":"Coping style and health related quality of life in aged lung cancer patients during hospitalization","volume":"36","author":"Shao","year":"2016","journal-title":"Chin J Gerontol."},{"key":"B14","volume-title":"Discussion on the Medical Treatment Mode to Improve the Quality of Life of Patients With Advanced Non-Small and Fine Lung Cancer","author":"Wang","year":"2017"},{"key":"B15","doi-asserted-by":"publisher","first-page":"174282","DOI":"10.3390\/cancers13174282","article-title":"Health-related quality of life and survival in metastasized non-small cell lung cancer patients with and without a targetable driver mutation","volume":"13","author":"Billingy","year":"2021","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejca.2018.05.005","article-title":"Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057","volume":"102","author":"Reck","year":"2018","journal-title":"Eur J Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3969\/j.issn.1674-8115.2011.03.021","article-title":"Analysis of influencing factors for quality of life of patients with non-small cell lung cancer","volume":"31","author":"Pan","year":"2011","journal-title":"J Shanghai Jiaotong Univ."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e200643","DOI":"10.1001\/jamanetworkopen.2020.0643","article-title":"Association of disease progression with health-related quality of life among adults with breast, lung, pancreatic, and colorectal cancer","volume":"3","author":"Marschner","year":"2020","journal-title":"J Am Med Assoc Netw Open."},{"key":"B19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","article-title":"Estimating an EQ-5D-5L value set for China","volume":"20","author":"Luo","year":"2017","journal-title":"Value Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11136-012-0200-0","article-title":"Developing the Chinese version of the new 5-level EQ-5D descriptive system: The response scaling approach","volume":"22","author":"Luo","year":"2013","journal-title":"Qual Life Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2217\/cer-2017-0069","article-title":"Health state utilities in patients with advanced non-small-cell lung cancer in China","volume":"7","author":"Shen","year":"2018","journal-title":"J Comp Eff Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7664\/CHE20170803","article-title":"The enlightenment of taking targeted health poverty alleviation on implementing universal medical insurance policy","volume":"36","author":"Xiang","year":"2017","journal-title":"Chin Health Econ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/ajco.12703","article-title":"Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: A multicenter cross-sectional study","volume":"14","author":"Liao","year":"2018","journal-title":"Asia Pac J Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fpubh.2019.00160","article-title":"Estimating the direct cost of cancer in Nepal: A cross-sectional study in a Tertiary Cancer Hospital","volume":"7","author":"Khatiwoda","year":"2019","journal-title":"Front Public Health."},{"key":"B25","first-page":"57","article-title":"Study on the economic burden of lung cancer inpatients from one Tertiary Hospital in Shanghai","volume":"32","author":"Huang","year":"2012","journal-title":"Chin Hosp Manag."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.2147\/OTT.S112501","article-title":"Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jnci.2015.11.002","article-title":"The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma","volume":"28","author":"Ezzat","year":"2016","journal-title":"J Egypt Natl Canc Inst."},{"key":"B28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.16770\/j.cnki.1008-9985.2012.09.017","article-title":"Influencing factor analysis on the economic burden of internal inpatients with lung cancer","volume":"19","author":"Huang","year":"2012","journal-title":"Hosp Admin J Chin PLA."},{"key":"B29","first-page":"525","article-title":"Analyzing the direct economic burden of hospitalized elderly poverty with chronic diseases in rural areas and its influencing factors","volume":"37","author":"Xiang","year":"2020","journal-title":"Chin Health Serv Manag."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00520-018-4419-3","article-title":"The humanistic burden associated with caring for patients with advanced non-small cell lung cancer (NSCLC) in three European countries-a real-world survey of caregivers","volume":"27","author":"Wood","year":"2019","journal-title":"Support Care Cancer."},{"key":"B31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.21147\/j.issn.1000-9604.2018.04.07","article-title":"Annual cost of illness of stomach and esophageal cancer patients in urban and rural areas in China: A multi-center study","volume":"30","author":"Yang","year":"2018","journal-title":"Chin J Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7664\/CHE20190616","article-title":"Hospitalization costs influencing factors analysis of patients with lung cancer operation based on the method of structural equation model","volume":"38","author":"Wang","year":"2019","journal-title":"Chin Health Econ."},{"key":"B33","first-page":"132","article-title":"Analyzing the relationship between the per case compensation cost from new rural cooperative system and the duration of hospitalization of inpatients","volume":"35","author":"Zhang","year":"2018","journal-title":"Chin Health Serv Manag."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1090623\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:17:24Z","timestamp":1683173844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1090623\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2023.1090623"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1090623","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"article-number":"1090623"}}